BELIMO Holding AG (SWX:BEAN)

Marinus Pharmaceuticals Income Statement

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,032	943.86	858.79	846.9	765.34	661.23
Revenue	1,032	943.86	858.79	846.9	765.34	661.23
Revenue Growth (YoY)	16.73%	9.91%	1.40%	10.66%	15.75%	-4.54%
Cost of Revenue	395.91	363.57	338.81	339.73	306.81	266.59
Gross Profit	635.93	580.29	519.98	507.17	458.53	394.63
Selling, General & Admin	290.79	274.45	251.5	242.03	213.25	199.85
Other Operating Expenses	91.09	88.26	80.17	76.1	66.89	56.65
Operating Expenses	419.76	399.17	367.51	354.81	313.17	287.77
Operating Income	216.17	181.13	152.47	152.36	145.36	106.86
Interest Expense	-	-1.02	-1.69	-0.6	-0.98	-1.17
Interest & Investment Income	7.09	0.81	0.37	0.14	0.26	0.1
Currency Exchange Gain (Loss)	-12.54	0.61	-8.56	-4.63	-0.75	-5.61
Other Non Operating Income (Expenses)	-5.37	-5.37	-0.18	0.24	-0.51	-0.6
EBT Excluding Unusual Items	205.35	176.15	142.41	147.51	143.38	99.59
Other Unusual Items	-	-	-	-	-	1.2
Pretax Income	205.35	176.15	142.41	147.51	143.38	100.79
Income Tax Expense	34.55	29.43	5.57	24.81	27.88	14.15
Earnings From Continuing Operations	170.8	146.72	136.85	122.7	115.5	86.64
Minority Interest in Earnings	-	0.06	0.12	0.1	0.17	0.07
Net Income	170.8	146.78	136.96	122.8	115.67	86.72
Net Income to Common	170.8	146.78	136.96	122.8	115.67	86.72
Net Income Growth	14.52%	7.17%	11.54%	6.16%	33.39%	-28.42%
Shares Outstanding (Basic)	12	12	12	12	12	12
Shares Outstanding (Diluted)	12	12	12	12	12	12
Shares Change (YoY)	0.01%	0.00%	0.01%	-0.01%	0.00%	-0.00%
EPS (Basic)	13.89	11.94	11.14	9.99	9.41	7.05
EPS (Diluted)	13.89	11.94	11.14	9.99	9.41	7.05
EPS Growth	14.50%	7.17%	11.53%	6.17%	33.39%	-28.42%
Free Cash Flow	122.48	136.09	118.62	70.17	114.11	102.88
Free Cash Flow Per Share	9.96	11.07	9.65	5.71	9.28	8.37
Dividend Per Share	9.500	9.500	8.500	8.500	8.500	7.500
Dividend Growth	11.77%	11.77%	-	-	13.33%	-
Gross Margin	61.63%	61.48%	60.55%	59.88%	59.91%	59.68%
Operating Margin	20.95%	19.19%	17.75%	17.99%	18.99%	16.16%
Profit Margin	16.55%	15.55%	15.95%	14.50%	15.11%	13.11%
Free Cash Flow Margin	11.87%	14.42%	13.81%	8.29%	14.91%	15.56%
EBITDA	244.88	208.42	178.53	178.33	169.53	129.51
EBITDA Margin	23.73%	22.08%	20.79%	21.06%	22.15%	19.59%
D&A For EBITDA	28.71	27.29	26.06	25.97	24.17	22.65
EBIT	216.17	181.13	152.47	152.36	145.36	106.86
EBIT Margin	20.95%	19.19%	17.75%	17.99%	18.99%	16.16%
Effective Tax Rate	16.82%	16.71%	3.91%	16.82%	19.44%	14.04%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.